In September 2022, Bureau Veritas announced the acquisition of Galbraith Laboratories Inc., a US-based expert in advanced analytical solutions for the healthcare sector.
This acquisition will further position Bureau Veritas in the Consumer Healthcare and Industrial Chemicals supply chains by connecting existing services to support upstream research and product development, from manufacturing to the end consumer.
Galbraith Laboratories Inc. offers testing solutions to a wide range of industries, including chemicals, healthcare, cosmetics, consumer goods, manufacturing and the environment. Founded in 1950 and headquartered in Knoxville, TN (USA), the company employs approximately 70 people and generated revenue of €8 million in 2021.
For more information, please read the press release available on our website.